Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...

Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...

As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

My mother also had osteoporosis.

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...

Breakthrough immunotherapy trials are showing unprecedented responses in a subset of rectal cancer patients, hinting at a ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...